Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretome CTS
NCT07723313Phase 1Recruiting
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial in carpal tunnel syndrome (CTS) (3 arms), sponsored by Prodia Stem Cell Indonesia. Primary endpoints: Boston Carpal Tunnel Questionnaire at 3 weeks and Electromyography at 3 weeks. Started Dec 2025; status: recruiting.
02
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT07723313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07723313.